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Abstract. We investigated the effects of the protein
phosphatase inhibitors okadaic acid and microcystin-LR
upon transport of newly synthesized proteins through
the exocytic pathway. Treatment of CHO cells with
1 uM okadaic acid rapidly inhibited movement of a
marker protein (vesicular stomatitis virus G protein)
from the endoplasmic reticulum to the Golgi compart-
ment . Both okadaic acid and microcystin-LR also in-
hibited transport in an in vitro assay reconstituting
movement to the Golgi compartment, at concentrations
equivalent to those required to inhibit phosphorylase
phosphatase activity. Inhibition both in vivo and in
vitro could be antagonized by protein kinase inhibi-
tors, suggesting that protein phosphorylation was di-
HOUGH generally considered a constitutive process L
LT
(Pfeffer and Rothman, 1987), transport of proteins
to the plasma membrane is regulated during cell di-
vision (Warren et al., 1983) . Using CHO cells infected with
a temperature-sensitive mutant of vesicular stomatitis virus
(VSV),' Featherstone et al . (1985) were able to show that
the initial stage oftransport (from theER to the Golgi com-
partment) was blocked during mitosis . This block, which was
coincident with a similar arrest in endocytosis (Berlin et al.,
1978 ; Warren et al ., 1984), is believed to be associated with
the disassembly and partitioning of single-copy organelles
between the two daughter cells (for review see Warren,
1989) . At present, the precise mechanisms responsible for
the mitotic arrest ofvesicular transport are unclear, although
the demonstration that endocytic vesicle fusion could be in-
hibited by p34cdc2 in vitro (Thomikowski et al ., 1989) has
led to the suggestion that one or more protein kinases might
be involved .
Protein phosphorylation is the major posttranslational
modification performed by eukaryotic cells, and is involved
in the regulation of a multitude of cellular processes (for re-
view see Edelman et al., 1987), including the cell cycle (for
1 . Abbreviations used in thispaper: endoD and endo H, endoglycosidases
D and H, respectively ; FBS, fetal bovine serum ; MC, microcystin-LR ;
MPF, maturation-promoting factor ; OKA, okadaic acid ; PP, protein serine/
threonine phosphatase ; VSV, vesicular stomatitis virus .
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rectly responsible for this effect . An early stage in the
transport reaction associated with vesicle formation or
targeting was inhibited by protein phosphorylation,
which could be reversed by fractions enriched in pro-
tein phosphatase 2A . Protein kinase antagonists did
not inhibit transport between sequential compartments
of the exocytic pathway in vitro, suggesting that protein
phosphorylation is not itself required for vesicular trans-
port . During mitosis, vesicular transport is inhibited
simultaneous to the activation of maturation-promoting
factor. It is proposed that the inhibition caused by
okadaic acid and microcystin-LR involves a similar
mechanism to that responsible for the mitotic arrest of
vesicular transport .
reviews see Nurse, 1990 ; Freeman and Donoghue, 1991) .
Thus, entry into mitosis is controlled by activation of
maturation-promoting factor (MPF), a serine/threonine pro-
tein kinase, which is itself regulated by several other ser-
ine/threonine and tyrosine kinases (Nurse, 1990) . However,
the level of phosphorylation of any given protein depends
upon the balance between kinase and phosphatase activities
acting upon individual sites, and mutations in protein phos-
phatase genes can also cause defects in the cell cycle (Doo-
nan and Morris, 1989 ; Booher and Beach, 1989 ; Kinoshita
et al ., 1990 ; Sneddon et al ., 1991) . Moreover, INH, a nega-
tive regulator of MPF, was identified as a form of protein
phosphatase 2A (Lee et al ., 1991) .
In contrast to the many protein kinases identified so far,
only a limited number of protein phosphatases have been
found . Indeed, all soluble serine/threonine phosphatases
(PPs) isolated to date belong to one of four subtypes based
upon the molecular properties of their respective catalytic
subunits (for review see Cohen, 1989) . Each subtype may
have several family members encoded by alternative splicing
or multiple genes, and at least five other genes encoding
potential protein phosphatase catalytic subunits have been
identified in mammalian and Drosophilia cDNA libraries
(Cohen et al ., 1990b) . Study of the role of PPs in cellular
processes has been greatly facilitated by the recent isolation
of two highly selective inhibitors, okadaic acid (OKA) (Bi-
alojan and Takai, 1988 ; Haystead et al ., 1989) and micro-
cystin-LR (MC) (MacKintosh et al ., 1990 ; Honkanen et al .,
13431990) . Both are extremely potent inhibitors of PP 1 and PP
2A (with K values in the nanomolar range for the isolated
catalytic subunits), are considerably less effective towards
PP 2B (micromolar K values), and have no effect upon PP
2C. OKA, and to a lesser extent MC, is also membrane per-
meant and can therefore be used to inhibit PP activity in in-
tact cells (for review see Cohen et al., 1990a). Evidence for
the involvement of PP 1 and PP 2A in the regulation ofmito-
sis has also been provided by experiments conducted with
OKA (Felix et al., 1989; Yamashita et al., 1990 ; Zheng et
al., 1991).
We now demonstrate that OKA inhibits protein transport
within the exocytic pathway in intact CHO cells, and that
both OKA and MC inhibit an assay which reconstitutes ER-
to-Golgi transport in vitro. Inhibition is dependent upon the
action of an as yet unidentified protein kinase, but can be
reversed by fractions enriched in PP 2A.
Materialsand Methods
Materials
OKA was obtained from Gibco Laboratories, Grand Island, NY, MC, H-8,
and staurosporine were from Calbiochem-Behring Corp., La Jolla, CA;
35S-translabel was from ICN Biomedicals Inc., Costa Mesa, CA; and
adenosine 5'-[-y 32p] triphosphate was from Amersham Corp., Arlington
Heights, IL. Other reagents, except where indicated, were obtained from
Sigma Chemical Co., St. Louis, MO.
Cellsand Viruses
Clone 15B CHO and NRK cells were maintained in monolayer culture in
minimal essential medium (a-MEM) supplemented with penicillin, strep-
tomycin, and 8% fetal bovine serum (FBS) (Gemini Bioproducts Inc.,
Calabasas, CA), in a 5% C02/95% air atmosphere. VSV (Indiana strain)
and the mutant straintsO45 (Flamand, 1970) were propagated in BHK cells
as described elsewhere (Pind et al., 1992) .
Infection and Labeling of Cells
Confluent monolayers ofclone 15B or NRK cells were infected with wild-
type or tsO45 VSV at a multiplicity of 10-20 plaque-forming units per cell
in a gassed incubator at 32°C (Beckers et al., 1987; Schwaninger et al.,
1991). Cells 3.5-4.5 h after infection were labeled with "S-translabel as
described previously (Beckers et al ., 1987). Briefly, cells infected with
wild-type virus were labeled with 200 g,Ci for 2.5 min at 37°C; and tsO45-
infected cells to be subsequently perforated were labeled with 100 /Xi for
10 min at 40°C, followed by an additional 2 min in the presence of 0.25
mM unlabeled methionine.
tsO45-infected cells that would not be perforated were labeled with 100
WCi for 3 min at 40°C, followed by an additional 2 min in the presence of
0.25 mM unlabeledmethionineand2.5 mg/mltrypsinwith occasional rock-
ing. The mediumwas then aspirated, the dish was transferred to an ice/wa-
ter bath, and the cells were washed three times withice-cold 50 mM Hepes,
pH 7.2, 90 mM K acetate containing 100 gg/ml soybean trypsin inhibitor
(50/90/STI). They were then removed from the dish by repeated pipetting
into the same buffer, washed, and resuspended in 50/90/STI at a density of
8 x 107 cells/ml. Greater than 95% of cells prepared in this way excluded
trypan blue.
Assay ofER-to-Golgi Transport In Vitro
Labeled cells were perforatedbythe hypotonic swelling and scrapingproce-
dure described previously (Beckers et al., 1987; Pindet al ., 1992). Semiin-
tactcells (-25-30Ag protein) were incubated at 32°C in an assay mix com-
prising 37 mM Hepes-KOH, pH 7.2, 78 mMK acetate, 2.5 mM Mg acetate,
5 mM EGTA, 1.8 mM CaC12, 1 mM ATP, 5 mM creatine phosphate, 0.2
IU creatinine phosphokinase (rabbit muscle), and 75 Wg rat liver cytosol,
in a final volume of 40 1L1 (Beckers et al., 1987, 1990). Assays containing
perforated NRK cells were supplemented with 1 mM UDP-N-acetylglu-
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cosamine (Schwaninger et al ., 1991). OKA and staurosporine were added
from stock solutions in 10% (vol/vol) DMSO, and MC was added from so-
lutions in 10% (vol/vol) methanol. In each case the final concentration of
solvent present did not exceed 0.5% (vol/vol).
At the end of the incubation, the perforated cells were collected by brief
centrifugation (Eppendorf microfuge, 10 s), incubated with endoglycosi-
dase D (endo D) (15B cells) or endo H (NRK cells), and analyzed by SDS-
PAGE and autoradiography, as described previously (Beckers et al., 1987;
Schwaninger et al., 1991; Pind et al., 1992). Autoradiographs were quanti-
tated by scanning densitometry (Beckers et al., 1987), and results expressed
as the percentage of the total G protein in the endo D-sensitive form
(GDs), or having one (GH0 or two (GH2) endo H-resistant oligosaccharide
chains, respectively.
Surface Immunoprecipitation
Clone 15B CHO cells, radiolabeled and trypsin released as described
above, were resuspended in a-MEM containing 5% FBS (1.6 x 106
cells/ml) and incubated as appropriate. The cells were then transferred to
ice, collected by centrifugation, washed once with ice-cold PBS containing
5 mg/ml BSA (PBS/BSA), and resuspended in PBS/BSA containing 80
lxg/ml antiVSV G protein (luminal epitope) (clone 8G5; Lefrancois and
Lyles, 1982) at a density of 8 x 106 cells/ml. After incubation on ice for
2 h with occasional mixing, the cells were collected, washed once with
PBS/BSA, and lysed in 50 mMTris-HCI, pH 7.5, containing 150 mM NaCI,
1% vol/vol Triton X-100, and 1 mM PMSF (TBS/TX). Lysates were
clarified by centrifugation (5 min at 16,000 g) and immune complexes re-
covered from the resulting supernatant with protein A-agarose. After sev-
eral washes with TBS/TX, immune complexes were eluted with boiling
SDS sample buffer and analyzed by SDS-PAGE, autoradiography, and scan-
ning densitometry.
Indirect Immunofluorescence
Clone 15B CHO cells were infected with tsO45 VSV as described above
with the exception that after the initial 45-min binding period at 30°C the
infection was continued at 40°C for an additional 3 h. Cells were then re-
moved from culture dishes by limited trypsinolysis at 40°C as described
above, and washed cells were resuspended in «-MEM containing 5% FBS
(1.6 x 106 cells/ml) and incubated as appropriate. They were then col-
lected by centrifugation, washed twice with ice-cold PBS, and fixed in 2%
paraformaldehyde in PBS for 10 min at room temperature. The fixed cells
were washed once in PBS and resuspended to a density of2 x 106 cells/ml
in PBS; and 200-,ul aliquots were transferred to round glass coverslips by
centrifugation (Cytospin 2; Shandon Southern Products Ltd., Runcorn,
UK). They werethen processed essentially as described previously (Plutner
et al., 1991) co-staining with antiVSV G protein (clone 8G5) and rabbit
anti-mannosidase II (generous gift of M. G. Farquhar, University of
California, San Diego) and subsequently with Texas red-conjugated goat
anti-mouse IgG (Molecular Probes, Inc., Eugene, OR) and FITC-
conjugatedgoatanti-rabbit IgG(Cappel; Organon TeknikaCorp., Durham,
NC), respectively. Images were viewed with a confocal scanning laser mi-
croscope (MRC-600; Bio-Rad Laboratories, Cambridge, MA), and pho-
tographed using Kodak TMAX film (Eastman Kodak Co., Rochester, NY).
Preparation ofCytosol
Adult male Sprague-Dawley rats (-250 g) were anesthetized, the livers ex-
sanguinated by perfusion through the hepatic-portal veinwith ice-cold PBS,
and excised. Washed livers were finely minced and homogenized in 3 vol
of 25 mM Hepes, pH 7.2, 125 mM K acetate (25/125) containing 1 mM
PMSF, 1 WM pepstatin A, 10 14g/ml leupeptin, and 5 pg/ml chymostatin
with 10 strokes of a tight-fitting dounce (Wheaton "200"; Thomas Sci.,
Swedesboro, NJ). The homogenate was centrifuged for 10 min at 15,000
rpm (Beckman JA 20 rotor; Beckman Instruments, Inc., Palo Alto, CA) and
the resulting supernatant further centrifuged for 90 min at 35,000 rpm
(Beckman SW41 rotor) . The lipid layer was aspirated and discarded; the
remainder of the supernatant was recovered and flash-frozen in liquid N2.
Aliquots, typically 15-20 mg/ml protein, were stored at -80°C.
Assay ofPhosphorylase Phosphatase
Glycogen phosphorylase was the generous gift of T. A. J Haystead, Univer-
sity ofWashington, Seattle, WA. [32P]Glycogen phosphorylase, inhibitor-2,
and the catalytic subunits of PP 1 and PP 2A were prepared essentially as
1344described by Cohen et al . (1988) . For the analysis of phosphorylase phos-
phatase activity in mock transport assays, 10-p1 aliquots containing mock-
radiolabeled semiintact cells were incubated in 25 mM Tris-HCl, pH 7 .4,
containing 0.5 mM EDTA, 0.5 mM DTT, 7.5 mM caffeine, and 1 .5 mg/ml
["P]glycogen phosphorylase (final volume 20 AI) at 37°C for 1 min . The
reaction was terminated by the addition of 100 Al 20% (wt/vol) TCA, and
the liberated [ 32P]phosphate determined by liquid scintillation counting
(Beckman LS5000TD) . Analysis of phosphorylase phosphatase activity in
cytosolic fractions and in membrane extracts was performed as described
by Cohen et al . (1988) .
Results
OKA Inhibits ER-to-Golgi Transport in Intact Cells
To investigate the effect ofOKA upon protein transport we
infected clone 15BCHO cells with the tsO45 mutant ofVSV
(Flamand, 1970) . At the restrictive temperature (40°C)
tsO45 G protein forms aggregates which cannot be exported
from the ER . Upon shift to the permissive temperature
(32°C) this block is released, and export proceeds at the nor-
mal rate . ERto-Golgi transport can be followed by deter-
mining the structure of the N-linked oligosaccharides as-
sociated with VSV G protein . Thus, arrival within the
cis-Golgi compartment is accompanied by the conversion of
the oligosaccharides to the Man s-G1cNAc2 form by the resi-
dent enzyme a-1,2-mannosidase I (Tabas and Kornfeld,
1979) . Since clone 15B cells are deficient in the enzyme
N-acetylglucosamine transferase I (GIcNAc Tr I) (Gottlieb
et al., 1975), N-linked oligosaccharides present on VSV G
protein transported through the cis-Golgi compartment and
beyond are uniquely sensitive to digestion by endo D (Mi-
zuochi et al., 1984) . The acquisition of sensitivity to endo
D can therefore be used as a measure of the arrival of VSV
G protein within the Golgi compartment in clone 15B cells .
Addition ofOKA directly upon shifting radiolabeled cells
to the permissive temperature had no effect (Fig . 1, lanes 1
and 2) . In contrast, preincubation of the cells at40°C for 15
min in the presence ofOKA (1 AM) abolished transport dur-
ing a subsequent chase at 32°C (lanes 3 and 4) . Inhibition
was not affected by preincubation of labeled cells with cyclo-
heximide (100 p,g/ml), but was partially antagonized by prior
incubation with the nonselective protein kinase inhibitor,
2-aminopurine (10mM), although this reagent itselfpartially
inhibited transport (lanes 5-8) . These results suggest that in-
hibition may involve the activity of a protein kinase, but does
not require additional protein synthesis .
To extend these results, two "wild-type" cell lines (CHO
and NRK) were treated with OKA under similar conditions .
Unlike clone 15B, these cells possess functional G1cNAc Tr
I (Gottlieb et al ., 1985), which renders N-linked oligosac-
charides insensitive to endo D (Mizuochi et al., 1984), but
allows processing to the complex form resistant to endo H
(a marker for arrival in the cis/medial-Golgi compartment
(Schwaninger et al., 1991) . In both cases, no endo H-resis-
tant VSV G protein could be detected in cells incubated in
the presence of OKA (data not shown) .
Although no previous reports have suggested that OKA
has any effect upon oligosaccharide-processing enzymes, we
considered it important to eliminate the possibility that the
observed effects resulted from the inhibition of one or more
of these enzymes rather than from a direct inhibition of
transport . Previous studies have demonstrated that move-
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Figure 1. OKA inhibits protein transport in intact CHO cells . Clone
15BCHO cells infected withts045VSVwerepulselabeled, washed,
and suspended in 50/90/STI as described inMaterials and Methods .
Aliquots (4 x 10 5 cells) were resuspended in u-MEM containing
5% FBS (1 .6 x 106 cells/ml) (lanes 1-4), or medium containing
100 wg/ml cycloheximide (lanes 5 and 6) or 10 mM 2-aminopurine
(lanes 7 and 8) . The suspensions were incubated on ice (lanes 1
and 2) or at 40 °C (lanes 3-8) for 5 min ; OKA was added to a final
concentration of 1 AM (lanes 2, 4, 6, and 8) ; and incubations were
continued for an additional 15 min . The suspensions were then
transferred to ice for 15 min and subsequently incubated at 32°C
for 45 min . Cells were collected by centrifugation and processed
as described in Materials and Methods . The amount ofG protein
present in the endo D-resistant (GDR) and -sensitive (GDs) forms
was determined by scanning densitometry, and transport assessed
as the percentage sensitive to endo D : (GD s/[GD s + GDR]) x
100 .
ment of VSV G protein to the cell surface is unaffected by
inhibition of N-linked oligosaccharide-trimming enzymes
(Burke et al ., 1984) . We therefore examined the effect of
OKA upon the surface expression ofG protein . As shown
in Fig . 2 (0), radiolabeled tsO45 VSV G protein could be
detected by surface immunoprecipitation within 30 min of
shifting cells to the permissive temperature, and reached a
maximum after 45 min ; kinetics consistent with those previ-
ously described (Pfeiffer et al ., 1985) . In contrast, treatment
ofclone 15BCHO cells withOKA completely abolished our
ability to detect radiolabeled G protein at the plasma mem-
brane (Fig . 2, 0) ; but did not influence the ability to precipi-
tate the protein from total cell lysates (data not shown) .
These results clearly demonstrate that treatment with OKA
directly inhibits vesicular trafficking in the exocytic pathway.
To further investigate the stage at which vesicular
trafficking was inhibited, we examined CHO cells infected
with tsO45 VSV by indirect immunofluorescence micros-
copy. After a 15-min incubation at the permissive tempera-
ture in the absence ofOKA, VSVG protein became concen-
trated in the perinuclear region and colocalized with the
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Figure 2. Effect of OKA on surface expression of VSV G protein.
Clone 15B CHO cellswere infected with tsO45 VSV, radiolabeled,
and trypsin released as described in Materials and Methods. Ali-
quots (8 x 105 cells) were incubated at 40°C in the presence (m)
or absence (o) of OKA (1 )M) for 15 min, incubated at 0°C for
an additional 15 min, andthenat32°C for times as indicated. Radio-
labeled G protein as recovered from the plasma membrane by im-
munoprecipitation as described in Materials and Methods.
Golgi marker protein mannosidase II (Fig. 3, A-D). How-
ever, in cells pretreated at the restrictive temperature with
OKA and shifted to the permissive temperature in the con-
tinued presence ofthe drug, VSV G protein showed a reticu-
lar staining pattern characteristic of retention within the ER
(Fig. 3, F and H). Interestingly, OKA-treated cells showed
a considerably more diffuse Golgi staining pattern than con-
trol cells, suggesting that the drug was inducing fragmenta-
tion ofthis organelle (Fig. 3, E and G). Despite this apparent
breakdown, analysis at high magnification confirmed that
VSV G protein and mannosidase II failed to colocalize in the
OKA-treated cells (Fig. 3, G and H, small arrows).
A similar result was obtained in cellsincubated at the per-
missive temperature for 45 min. In this case control cells
showed significant peripheral staining of VSV G protein
(Fig. 3 l, broadarrows), consistent with our ability to detect
the protein by surface immunoprecipitation, whilethe distri-
bution of G protein in OKA-treated cells was essentially un-
changed from that observed after 15 min, and did not
colocalize with mannosidase II (Fig. 3, M-P) .
MC and OKA Inhibit ER-to-Golgi Transport
in Semiintact Cells
To further investigate the molecular basis of the effects of PP
inhibitors on protein trafficking, experiments were con-
ducted with "semiintact cells." These are a population of cells
which have been permeabilized by mechanical shear under
conditions which cause the removal of the soluble contents,
but which allow the retention of secretory organelles in a
functionally intact form. Transport of protein from the ER
to the Golgi compartment in semiintact cells is dependent
upon the addition of ATP and a high-speed supernatant
("cytosol") (Beckers et al., 1987, 1990; Schwaninger et al.,
1991; for reviews see Balch, 1989, 1990) .
Addition of either MC (1.25 p,M) or OKA (2 .5 E4M) to the
in vitro transport assay caused a 70% reduction in the
amount of VSV G protein transported to the Golgi compart-
ment in a cytosol-dependent manner (Fig. 4, columns 1-5) .
To investigate whether the phosphatases involved in this inhi-
bition were present exclusively in either the membrane or
cytosolic fractions, semiintact cells and cytosol were
pretreated separately with MC on ice, and excess inhibitor
removed by pelleting or gel filtration, respectively. Assays
were then conducted using combinations of treated and
mock-treated components. Little inhibition was observed
when the assay contained either mock-treated semiintact
cellsor cytosol (Fig. 4, columns 6and 7), whereas inhibition
equivalent to that obtained by the direct addition of MC oc-
curred when treated semiintact cells and cytosol were com-
bined (column 8) . This result indicates that the PPs whose
inhibition by OKA and MC is responsible for the observed
arrest in transport are not localized exclusively to the mem-
brane fraction, although as this fraction likely contains some
residual cytosolic components we cannot be completely cer-
tain that the relevant phophatase(s) are not exclusively cyto-
solic.
As shown in Fig. 5, both MC and OKA inhibited protein
transport in a dose-dependent fashion consistent with their
effects on protein phosphatase activity. Half-maximal inhibi-
tion of transport was obtained at -40 nM MC and 150 nM
OKA, respectively (Fig. 5) . In other experiments, half-
maximal values ranging from 30 to 100 nM MC and 100 to
500 nM OKA were obtained (data not shown), but in each
case the overall relationships were maintained. Thus, (a) no
inhibition oftransport was observed when >50% of the max-
imal phosphorylase phosphatase activity remained (a mea-
sure of PP 1 and PP 2A activity), (b) MC was approximately
fourfold more potent than OKA, and (c) maximal inhibition
of transport was 60-80% of the cytosol-dependent signal .
The variability between experiments probably results from
differences between individual preparations of semiintact
cells, which typically contained 30-50% of the total phos-
phorylase phosphatase activity present in the assay.
MC Inhibits an Early Step in Transport
Analysis of protein transport in vitro has revealed an appar-
Figure 3. OKA blocks export from the endoplasmic reticulum. Clone 15B CHO cells infected with tsO45 VSV were released from culture
dishes by limited trypsinolysis. Aliquots (4 x 103 cells) were resuspended in a-MEM containing 5 % FBS (1.6 x 106 cells/ml) in the ab-
sence (A-D and 1-L) or presence (E-Hand M-P) of 1 IM OKA and incubated at 40°C for 15 min. The suspensions were then transferred
to ice for 15 min and subsequently either maintained on ice (A and B) or incubated at 32°C for 15 min (C-H) or 45 min (I-P) . Cells
were collected by centrifugation and processed for indirect immunofluorescence as described in Materials and Methods. Golgi compart-
ments were detected by staining with an antisera to mannosidase II (A, C, E, 1, K, M, and O) or VSV G protein (B, D, F, H, J, L, N,
and P) . Images were photographed at low magnification (A-F, I, J, M, and N) or high power (G, H, K, L, O, and P) . Small arrows indicate
Golgi region and broad arrows the cell surface.
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Figure 4. MC and OKA inhibit protein transport in semiintactcells
(SCs). Clone 15B CHO cells were infected with tsO45 VSV, radio-
labeled, and SCs prepared as described in Materials and Methods.
Aliquots were assayed in the absence or presence of OKA (2.5 JIM)
or MC (1.25 uM), respectively. MC-treated SCs were prepared by
resuspending SCs in 50/90 containing 1 .25 ,M MC, incubating on
ice for 10 min, and collecting the SCs by centrifugation (3 min at
500 g; 4°C). They were then resuspended in 50/90 without inhib-
itor. MC-treated cytosol was prepared by incubating cytosol (100
Eel) with 1 tM MC, on ice for 15 min, and centrifuging (5 min at
1,500 g) through a 1-ml column ofBiogel P6-DG (Bio-Rad Labora-
tories, Richmond, CA) equilibrated with 25/125.
ent lag between the budding of carrier vesicles from the ER,
and their fusion with the cis-Golgi compartment (Beckers et
al., 1990; for review see Balch, 1989) . Since the results of
our immunofluorescence studies suggested that PP inhibition
affects the "early (budding and targeting) steps (Fig. 3), we
examined whether this was also the case in vitro. MC was
added at various times during the course of a 90-min incuba-
tion and the amount of G protein which had become resistant
to the action of the inhibitor determined. A time-dependent
increase in the amount of VSV G protein resistant to the ac-
tion ofthe inhibitor was observed (Fig. 6, "). Thus, -60%
of the transportable G protein (0.46/0.79) was resistant after
15 min of the incubation ("), a time at which <10%
(0.06/0.79) had been transported to the cis-Golgi compart-
ment (O). The rate at which VSV G protein became resistant
to the action of MC was similar to that observed with other
"early" inhibitors such as GTPyS and the anti-rablb mono-
clonal 4D3c (Beckers et al., 1990; Plutner et al ., 1991), con-
sistent with the hypothesis that the component(s) involved
The Journal of Cell Biology, Volume 116, 1992
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Figure 5. Concentration dependence ofOKA- and MC-mediated in-
hibition of protein transport and phosphorylase phosphatase activ-
ity in semiintact cells. Clone 15B CHO cells were infected with
tsO45 VSV, radiolabeled (m) or mock-labeled (o), and semiintact
cells prepared as described in Materials and Methods. Aliquots
were assayed for protein transport (m) or phosphorylase phospha-
tase activity (o) in the presence of MC (top) or OKA (bonom) as
described in Materials and Methods. For protein transport, results
are expressed as the percentage uninhibited of the maximum inhib-
itable transport. Maximal transport was 70% and uninhibitable
transport 26.9 % . Maximal phosphorylase phosphatase activity was
6.5 mU/ml.
are normally dephosphorylated during the initial stages of
vesicular transport, and with our observations of the distri-
bution of VSV G protein in OKA-treated cells.
Inhibition Is Dependent upon ATP Concentration and
Can Be Prevented by Protein Kinase Antagonists
The extent ofphosphorylation ofany substrate depends upon
the balance between the competing action ofprotein kinases
and phosphatases. Consequently, although PP inhibitors act
directly to prevent dephosphorylation, in most instances
they indirectly cause hyperphosphorylation due to the con-
tinued action of protein kinases (Cohen et al ., 1990a) . The
partial antagonism between OKA and 2-aminopurine ob-
served in intact cells(Fig. 1) is consistent with the hypothesis
thatthe mechanism oftransport inhibition involves increased
protein phosphorylation, rather than decreased dephosphor-
ylation per se. We therefore decided to investigate the poten-
tial role of protein kinases in protein trafficking.
Analysis of ER-to-Golgi transport in vitro is routinely
conducted in a buffer containing 1 mM ATP However, in the
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Figure 6. MC inhibits an early stage in vesicular transport. Semi-
intact cells prepared as described above were assayed at 32°C. At
various times during the incubation, individualaliquots were either
transferred to ice (o), or MC was added to a final concentration
of 1.25 AM, and the incubation continued for the remainder of a
total of 90 min (n).
presence of a regenerating system, <20 AM is actually re-
quired for a maximal signal (Beckers, C. J. M., and W. E.
Balch, unpublished observation). Although protein kinases
typically have Km values for ATP in the region of 10 AM
and might therefore be expected to be almost maximally ac-
tive under these conditions we examined whether altering
the nucleotide concentration influenced the degree of inhibi-
tion observed.
In these experiments the basal ATP concentration was
-25 AM. Increasing the concentration of MgATP between
25 AM and 2.5 mM did not affect the amount of G protein
transported to the Golgicompartment in control incubations
(Fig. 7, 0) . In contrast, MC-mediated inhibition of ER-to-
Golgi transport increased from -40% of the cytosol-
dependent signal at 25 AM ATP to >75 % at 2.5 mM (Fig.
7, ") . This result confirmed the direct involvement of one
or more protein kinases in the inhibitory process, with the
overall reaction having an apparent Km for ATP of ti 30 AM.
To further investigate the mechanism responsible for the
inhibition of transport, the effects of selected protein kinase
antagonists were examined. In the presence of a 1-mM ATP-
regenerating system, 2-aminopurine (5 mM), H-7 (0.8 mM),
and H-8 (1 mM) did not affect transport in control assays.
However, these inhibitors antagonized MC- or OKA-
mediated inhibition by 40, 50, and 95 %, respectively (data
not shown). Inhibition of transport by PP inhibitors could
also be antagonized by staurosporine (2.5 AM) . Accord-
ingly, we used this reagent to analyze the temporal aspects
of MC-mediated inhibition. As shown in Fig. 8, a time-de-
pendent loss in the ability of staurosporine to prevent inhibi-
tion was observed, with 50% maximal inhibition occurring
when the addition of MC and staurosporine were separated
by -5.5 min. A similar result was obtained using H-8 (data
not shown).
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Figure 7 . ATP dependence of MC-mediated inhibition. Semiintact
cells prepared as described in Materials and Methods were assayed
in buffers containing ATPregenerating systems buffered at 0-2.5
mM ATPand in the absence (o) or presence (m) of MC (1.25 AM).
Both staurosporine and H-8 are potent inhibitors of pro-
tein kinase C and cyclic nucleotide-dependent protein ki-
nases, but will also inhibit other protein kinases (for review
see Ruegg and Burgess, 1989). Experiments designed to
directly investigate the potential role of protein kinase C in
the inhibitory process demonstrated that MC-mediated inhi-
bition occurred in the absence of Cal+. Thus, inhibition oc-
curred when incubations with MC were conducted in the
presence of EGTA, and staurosporine was added simultane-
ous to the addition of Cal+ to relieve the EGTA block of
0 10 20 30
Time (min)
H
Figure 8. Kinetics of MC-mediated inhibition of protein transport.
Semiintact cells prepared as described in Materials and Methods
were assayed in the presence of MC (1.25 AM). At times indicated,
staurosporine was added to a final concentration of 2.5 AM, and
the incubationcontinued fora total of90 min. Results are expressed
as the percentage of maximal inhibition.transport (data not shown). In addition, inhibitory peptides
specific for protein kinase C, CAMP-dependent protein ki-
nases, and Cal+/calmodulin-dependent protein kinase II did
not prevent MC-mediated inhibition when added to 100 N,M,
concentrations equivalent to those capable of completely in-
hibiting the target enzymes in microinjection studies (for re-
view see Hardie, 1988). Together these data argue against
the involvement of protein kinase C, cAMP-dependent pro-
tein kinases, or Cal+/calmodulin-dependent protein kinase
II in the modulation of protein trafficking, although the pos-
sibility that an isozyme ofprotein kinase C that is insensitive
to both Cal+ and the autoinhibitory peptide is involved can-
not be excluded.
cis-to-medial Intra-Golgi 7lransportIs Inhibited by MC
but Unaffected by Staurospoyine
If transport between adjacent compartments of the exocytic
pathway involved the cyclic phosphorylation and dephos-
phorylation of particular components, it would be expected
that inhibition of either phosphorylation or dephosphoryla-
tion would arrest transport. Thus, the ability to antagonize
MC- and OKA-mediated inhibition of transport by nonselec-
tive protein kinase inhibitors suggested that the components
involved in vesicular transport are not ordinarily phos-
phorylated during individual cycles of budding and fusion.
However, this possibility could not be completely elimi-
nated, given the inhibitory effect of 2-aminopurine upon in-
tact cells (Fig. 1) and the rapid entry of VSV G protein into
a MC- and OKA-resistant state in vitro (Fig. 6) .
To directly investigate the potential role of protein phos-
phorylation in vesicular transport in the absence of PP inhib-
itors we took advantage of our recent success in extending
the in vitro ER-to-Golgi transport assay to encompass the se-
quential movement ofVSV G protein to the medial cisternae
(Schwaninger et al., 1991) . Since this involves two tem-
porally distinct rounds of budding and fusion, we examined
whether differences existed between the effects of protein
phosphatase and protein kinase inhibitors on the two in-
dividual reactions. NRK cells were infected with wild-type
VSV, and transport to the cis and medial compartments was
determined by the appearance of the GH, and GH2 forms of
G protein, respectively (Schwaninger et al ., 1991). Inclusion
ofMC in the incubation medium inhibited transport from the
ER to the cis-Golgi compartment (GH, + GH2) by -30%,
with the majority of the transported VSV G protein present
in the GH, form (Fig. 9, A and B; "). This result indicates
that MC inhibits transport both to and from the cis-Golgi
compartment, and is similar to that obtained with GTP-yS,
another "early" inhibitor which blocks both transport events
(Schwaninger et al., 1991; and data not shown). Moreover,
consistent with the inhibition of an early step in both ER-to-
cis and cis-to-medial Golgitransport, addition ofMC at later
times during the incubation resulted in the rapid accumula-
tion of inhibitor-resistant VSV G protein, and a coordinate
decrease in the ratio of GH, to GH2 (Fig. 9, A and B) .
Under the above conditions, MC-mediated inhibition was
also antagonized by staurosporine, which itself did not
influence control incubations (Fig. 9, C). The observation
that transport was not inhibited when MC and staurosporine
were both present argues against MC-mediated inhibition in
the absence of staurosporinebeingan artefactdue to the inhi-
bition of any of the oligosaccharide-processing enzymes
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Figure 9. Effects of MC and staurosporine on intra-Golgi transport.
Semiintact cells were prepared from NRK cells infected with wild-
type VSV as described in Materials and Methods, and assayed in
the presence of UDP-N-acetylglucosamine. (A and B) At the times
indicated aliquots were transferred to ice (o), or MC was added to
a final concentration of 1.25 uM and the incubation continued for
the remainder of the 120-min time course (e) . The semiintact
cells were then collected and processed with endo H as described
previously (Schwaninger et al., 1991). Results are expressed as the
percentage of VSV G protein in the GH, (A) or GH2 (B) form, re-
spectively. (C) Semiintact cells were assayed for a total of 120 min
in assay mix alone (1), or assay mix containing 1.25 p.M MC (2),
1.25 AM MC + 2.5 1zM staurosporine (3), or 2.5 uM staurospo-
rine (4), respectively. Results are expressed as the percentage of G
protein present as the GH2 form.
responsible for creating resistance to endo H, and is consis-
tent with our hypothesis that a similar inhibitory mechanism
is involved in 15B CHO and NRK cells. Both ER-to-cis and
cis-to-medial transport were also inhibited by MC and OKAin semiintact wild-type CHO cells (data not shown) . In addi-
tion, since the protein kinase antagonistdid not inhibit trans-
port in either oftwo sequential rounds ofbudding and fusion,
these results are consistent with the hypothesis that protein
phosphorylation causes an arrest in transport ; and that it is
not ordinarily part ofthemechanism by which vesicles move
between adjacent compartments . However, the possibilities
that transport ordinarily involves a protein kinase resistant
to inhibition by the antagonists used and that a distinct en-
zyme is responsible for the inhibition of transport cannot be
excluded .
Inhibition CanBe Reversed by Fractions Enriched in
Protein Phosphatase 2A
The results described above suggested that one or more of
the components involved in vesicular transport must be
maintained in the dephosphorylated state, and that either PP
1 or PP 2A is responsible . Although both OKA and MC
show higher affinity forPP2A thanPP 1(Bialojan and Tàkai,
1988 ; Haystead et al., 1989 ; MacKintosh et al ., 1990 ;
Honkanen et al ., 1990), we could not be certain that the
results described in Fig . 5 implicated either enzyme, at least
in part because of the indirect nature oftransport inhibition .
To determine whether PP 1 or PP 2A alone was required to
maintain the dephosphorylated state, we examined whether
MC-mediated inhibition could be reversed .
As protein phosphorylation appears necessary to generate
the inhibitory state, semiintact clone 15B CHO cells were
incubated with cytosol andMC at32°C for 20min to allow
maximal inhibition to occur (Fig . 8) . They were then
pelleted, resuspended in a second mix without MC, and in-
cubated for an additional 90 min . As shown in Fig . 10 A, no
inhibition was observed when the second mix contained un-
treated cytosol (columns 1 and 4) . In contrast, inhibition
equivalent to thatobtained in the continuous presence ofMC
was observed when the final incubation mix contained
cytosol preincubated with MC (columns 2 and 5) . These
results were not influenced by the presence or absence of
protein kinase antagonists in the second incubation mix, in-
dicating that protein(s) in the untreated cytosol had reversed
the inhibition which had occurred during the preincubation .
Addition of the purified catalytic subunits ofPP 1 and PP
2A to MC-inhibited semiintact cells in the presence ofMC-
treated cytosol did not reverse the inhibition (data not
shown), although in control experiments limited phosphory-
lase phosphatase activity could be detected after incubation
under these conditions. The catalytic subunits do not nor-
mally exist in a free state, and the presence ofthe regulatory
subunits may influence activity towards particular substrates
(Sola et al ., 1991) . We therefore prepared fractions enriched
in the holoenzymes of the two PPs . Analysis of the rat liver
cytosol used in the reversal assay indicated that it contained
Figure 10. Reversal ofMC inhibition. (A) Semiintact clone 15B cells were assayed directly from ice (control SCs), or preincubated for
20 min at 32°C in assay mix containing 1.25 uM MC, pelleted, and resuspended in 50/90 (Inhibited SCs) . Aliquots ofinhibited SCs were
subsequently incubated foran additional 90 min inthe presence ofcontrol or MC-treated cytosols as indicated, augmented with the heparin-
agarose nonbinding fraction ofcytosol (HNB), heparin-agarose eluate (HE), orCHO cell membrane extract (ME) (-1 mU/ml phosphor-
ylase phosphatase activity), respectively . MC-treated cytosol was prepared by incubating aliquots (100 A1) made 1 mM in MgATP and
1 AM MC at 32°C for 10 min, and then centrifuging through Biogel P6-DG equilibrated in 25/125 containing 100 pMMgATP (B) HNB,
HE, and ME fractions were prepared essentially as described by Pondaven and Cohen (1987) using rat liver cytosol and CHO 15B cell
homogenates, respectively, and centrifuged through Biogel P6-DG columns equilibrated with 25/125 containing 0.25 mM Na mercapto-
ethanesulphonic acid, to remove buffer constituents inhibitory to the transport assay. Phosphorylase phosphatase activity was measured
in the absence (n) or presence (s,) of inhibitor-2 as described in Materials and Methods.
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135 1-20 mU phosphorylase phosphatase per ml of which
30-40% was type 1 (inhibited by inhibitor-2 ; Cohen, 1989 ;
Fig . 10B ; and data not shown) . We fractionated this cytosol
by heparin-agarose chromatography to resolve PP 1 andPP
2A (Erdodi et al ., 1985 ; Pondaven and Cohen, 1987) . As ex-
pected, in the presence of 0.1 M KCl PP 2A was eluted in
the unbound fraction, whereas PP 1 boundto the column and
was eluted by 0.5 M KCl (Fig . 10, B) . Subsequent analysis
indicated that MC-mediated inhibition was reversed by the
heparin-agarose unbound fraction, but not by equivalent ac-
tivities of the bound and eluted fraction (Fig . 10, columns
6 and 7) .
In a second approach, a 0.5-M KCl extract of CHO post-
nuclear membranes was prepared (Pondaven and Cohen,
1987) . This contained -22 mU phosphorylase phospha-
tase/ml, of which -90% was inhibitable with inhibitor-2
(type 1) . As shown in Fig . 10 (column 8), the CHO cell ex-
tract, like the heparin-agarose bound fraction of cytosol
(column 7), was unable to reverse MC-mediated inhibition
under the assay conditions used .
In additional experiments, gel filtration chromatography
of unfractionated cytosol revealed a major peak of reversal
activity of 100-180 kD, and reversal activity was associated
with the major peaks of casein phosphatase activity when
cytosol was fractionated by anion exchange chromatography
(data not shown) . These data are consistent with the distribu-
tion of the PP 2A holoenzymes, and together they suggest
that inhibition of PP2A is primarily responsible for causing
inhibition of protein transport .
MC-inhibited Semiintact CellsRemain Sensitive to
Other "Early" Transport Inhibitors
The morphological and biochemical data presented above
indicate that treatment of cells with phosphatase inhibitors
blocks exocytic transport at an early step presumably related
to priming or budding ofthe donor compartment . Our ability
to reverse this inhibition using fractions enriched in PP 2A
allowed us to ask whether the inhibited membranes re-
mained sensitive to other kinetically "early inhibitors such
as GTPyS and the inhibitory monoclonal antibodies to
rablb, or had progressed beyond any of these stages . Semnn-
tact CHO 1513 cells were incubated on ice or at 32°C in the
presence or absence of MC (1 .25 tLM) for 30 min and col-
lected by centrifugation . They were then resuspended in
fresh assay mixtures containing untreated cytosol and
selected inhibitors . As shown in Fig . 11, cells incubated at
32°C in the absence ofMC were almost completely resistant
to subsequent inhibition by MC, GTPyS, or monoclonal
4D3c (stippledcolumns) . In contrast, virtually no additional
VSV G protein to that which had escaped the initial inhibi-
tion by MC was transported to the Golgi compartment when
reversal was conducted in the presence of MC, GTPyS, or
4D3c (shaded columns) .
Discussion
The results described above demonstrate that transport of
newly synthesized proteins from the ER to the Golgi com-
partment is inhibited by exposure to inhibitors of protein
phosphatases . However, treatment of cells with OKA pro-
duces marked hyperphosphorylation (Haystead et al ., 1989 ;
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Figure 11. Inhibited semiintact cells remain sensitive to early trans-
port inhibitors . Semiintact clone 1513 cells were either maintained
on ice (a), or incubated at 32°C in assay mixture with (o) or with-
out (n) 1.25 1,M MC for 30 min, collected by centrifugation, and
resuspended in 50/90. Cell aliquots were then added to fresh assay
mixtures containing MC (1.25 uM), GTPyS (10,uM), or mono-
clonal 4D3c (2 .5 iAg), respectively, and either directly incubated at
32°C for 90 min (control, MC, and GTPyS) or preincubated at0°C
for 90 min to allow antibody binding and subsequently at 32°C for
an additional 90 min (4D3c) . ER-to-Golgi transport was assessed
as described in Materials and Methods.
Cohen et al., 1990a ; Zheng et al., 1991) . At least three
pieces of evidence support the conclusion that protein phos-
phorylation, rather than a lack of protein dephosphorylation
per se, is actually responsible for the inhibition of transport
observed in the present study : (1) inhibition of transport in
intact cells was antagonized by the nonspecific protein ki-
nase inhibitor, 2-aminopurine ; (2) MC-mediated inhibition
of semiintact cells was sensitive to the concentration ofATP,
and (3) inhibition in vitro could be antagonized by simul-
taneous treatment with protein kinase inhibitors such as
staurosporine and H-8 .
At present the identity of the protein kinase(s) responsible
for the inhibition remains unclear . Since the mitotic arrest
of vesicular transport appears temporally related to the acti-
vation ofMPF (Featherstone et al., 1985 ; Nurse, 1990), this
kinase is obviously an attractive candidate . However, the
results obtained do not support this hypothesis. For example,
MPF kinase activity is absent during interphase and requires
cyclin synthesis for activation (for review see Nurse, 1990),
whereas inhibition of transport in intact cells was not
prevented by protein synthesis inhibitors . In addition, the rat
liver cytosol used in the present study had no detectable his-
tone Hl kinase activity (Smythe, C ., and H . W. Davidson,
unpublished observation), and did not acquire such activity
when incubated with semiintact cells and MC under condi-
tions which inhibited protein transport (data not shown) .
Similarly, cytosol prepared from nocodazole-arrested HeLa
cells, containing active MPF both before and after incuba-
1352tion, supported transport to the same extent as interphase
cytosol (data not shown) .
Evidence that MPF may not be solely responsible for the
inhibition of other membrane-related events associated with
the entry into mitosis has come from the results oftwo recent
studies. In the first, treatment of Xenopus egg extracts with
OKA caused dissociation of nuclear membranes from chro-
matin and couldbe antagonized by protein kinase inhibitors
(Pfaller et al., 1991) . However, dissociation couldnot be in-
duced by purified MPF Secondly, despite the observations
of Tuomikowski et al . (1989), MPF does not appear to be
responsible for the OKA-mediated inhibition of endocytic
vesicle fusion in vitro (Woodman et al., 1992).
Several other protein kinases have been implicated in the
control of events associated with the cell cycle, including
protein kinase C, cAMP-dependent protein kinases, and
Cat+/calmodulin-dependent protein kinase II (Levin et al.,
1990; Lamb et al ., 1991; Baitinger et al., 1990). MC-
mediated inhibition of transport was not prevented by
specific peptide inhibitors of these enzymes. Inhibition by
staurosporine has been considered diagnostic of the involve-
ment of protein kinase C (Thmaoki et al., 1986) but this in-
hibitor acts at the ATP-binding site which is highly homolo-
gous to those of other serine-threonine-specific kinases
(Tàmaoki et al ., 1986; Edelman et al., 1987) and will inhibit
a variety of other protein kinases in vitro (Ruegg and Bur-
gess, 1989). Moreover, the involvement of protein kinase C
or Cat+/calmodulin-dependent protein kinase II in the inhi-
bition of ER-to-Golgi transport is unlikely since inhibition
occurred in the absence of Cat+. The identification of the
kinase responsible for inhibiting transport is currently under
investigation.
In contrast to our uncertainty regarding the identity of the
protein kinase(s) involved in the inhibition ofvesicular trans-
port, we are more confident that PP 2A is the enzyme
responsible for preventing the inhibition during interphase.
The reversal of MC-mediated inhibition by untreated
cytosol, but not by MC-treated cytosol, under conditions
where components other than PPs were not limiting, sug-
gests that a soluble rather than a membrane-associated en-
zyme is involved. This conclusion does not conflict with the
observation that treatment of both soluble and membrane
components of the assay were required for maximal inhibi-
tion, since our semi-intact preparations generally contain
some residual soluble components (Beckers et al., 1987) .
Typically, the cellscomprised 30-50% of the totalphospha-
tase activity present in the assay (including both type 1 and
2A) . When PP 1 and PP 2A were separated by heparin
affinity chromatography (Erdodi et al., 1985; Pondaven and
Cohen, 1987) reversal of inhibition was observed using the
unbound fraction, but not with the bound and eluted mate-
rial. This result is consistent with the distribution of type 2A
activity. Furthermore, proteins of an apparent molecular
weight equivalent to that of type 2A phosphatase holoen-
zymes, and coeluting with these enzymes after anion-
exchange chromatography (Cohen, 1989), were able to re-
lieve the block in transport. However, we were unable to
reverse inhibition using the purified catalytic subunits of ei-
ther phosphatase type 1 or 2A. Sola et al . (1991) demon-
strated that PP 2A holoenzymes showed a significantly
higher ratio of histone Hl phosphatase (phosphorylated by
p34cdcz) to phosphorylase phosphatase activity than did the
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free catalytic subunits. Thus, although we do not believe that
p34CdCz is directly responsible for the phosphorylation
events in the present study, we think it likely that our failure
to demonstrate reversal by the catalytic subunit of PP 2A
reflects a failure to add sufficient functional enzymatic activ-
ity rather than an absolute requirement for the regulatory
subunits. Nevertheless, we cannot completely eliminate the
possibility that a PP with properties highly similar to, but
distinct from, type 2A is actually responsible.
At present we also cannot completely eliminate the possi-
bilities that PP 1 is able to reverse the inhibition, if added
at sufficiently high concentrations, or that a factor necessary
for PP 1 to affect reversal is lost during the 0.5 M KCl treat-
ments inherent in our preparations of this enzyme. However,
on balance we believe it likely that PP 2A is the protein phos-
phatase that is primarily responsible for maintaining protein
transport in an uninhibited state.
PP 2A has been implicated in the regulation ofother events
which occur during the onset of mitosis, including the dis-
sociation of nuclear membranes from chromatin (Pfaller et
al., 1991) and the inhibition of endocytic vesicle fusion
(Woodman et al., 1992). PP 2A has also been identified as
a negative regulator of the activation of MPF (Felix et al.,
1989; Kinoshita et al., 1990; Lee et al., 1991); its inhibition
may underlie the induction of a mitosis-like state by OKA
(Yamashita et al., 1990; Zheng et al., 1991).
The results obtained in this study suggest that an early
event in transport, presumably related to the formation or
budding of vesicles, is inhibited by protein phosphorylation;
consistent with the inhibition of export observed during
metaphase (Featherstone et al., 1985). Thus, VSV G protein
retained an "ER-like" distribution in OKA-treated CHO cells
incubated at the permissive temperature, transport rapidly
became resistant to the addition of MC or OKA in vitro,
while inhibited semiintact cells rescued by cytosol fractions
enriched in PP 2A remained sensitive to other "early" inhibi-
tors (e.g., GTP-yS ; Beckers et al., 1990) at incubation times
when control cells were almost completely resistant. This in-
hibition couldnot be attributed to a failure to dissolve tsO45
G protein aggregates after incubation at the restrictive tem-
perature since this is largely completed during the incuba-
tions on ice in the preparation of the semiintact cells (Balch,
W E., unpublished observation). In addition, inhibition was
also observed in cells infected with wild-type virus, and
movement from cis to medial Golgi compartments was also
blocked.
In contrast to the complete inhibition of transport ob-
served in vivo, a relativelylarge proportionof VSV G protein
was transported to the cis-Golgi compartment in the continu-
ous presence of MC or OKA in vitro (typically 30-40% of
the cytosol-dependent signal in semiintact cells infected with
tsO45 and up to 70% in those infected with wild-type virus).
This signal was not merely the result of a general slowing
of transport since no additional movement was observed
when incubations in the presence of MC were prolonged for
up to 4 h (our unpublished observation) . The existence of a
significant fraction of VSV G protein which is resistant to
inhibition from ice in vitro is consistent with vesicle forma-
tion beingthe stage at which transport is arrested, especially
given the apparent indirect nature of the inhibitory mecha-
nism. Thus, in orderto completelyinhibit transport in intact
cells, it was necessary to treat them with OKA for 15 min
1353under conditions where the marker protein (tsO45 G pro-
tein)was retained within the ER. However, in contrast to the
reversible phenotype observed with intact cells, shifting
semiintact cells to 40°C in vitro causes an irreversible con-
formational change in tsO45 G proteinwhich prevents subse-
quent biochemical analysis of transport (Balch, W E., un-
published observation). Consequently, it was not possible to
preincubate semiintact cells using the standard assay in the
presence of ATP (to allow phosphorylation to occur) under
conditions which would prevent export, precluding the es=
tablishment of a completely inhibited state in vitro. Condi-
tions are currently being developed to address this problem.
The observation that MC-mediated inhibition could not be
reversed by MC-treated cytosol suggests that relief of the in-
hibition involves the dephosphorylation of a component as-
sociated with the cell membranes at the end ofthe preincuba-
tion. At present many of the components required for
vesicular transport remain poorly characterized, making
identification of the protein(s) which become phosphor-
ylated a technically difficult task. One intriguing possibility
is that they might include members of the rab gene family
of low molecular weight GTP-binding proteins (Touchot et
al., 1987), which have been implicated in several stages of
vesicular transport (for review see Balch, 1990) . Recently,
it was shown that two members of this family, rab lp (impli-
cated in ER-to-Golgi transport; Plutner et al., 1991) and rab
4p (localized to early endocytic vesicles ; van der Sluijs et
al., 1991), were hyperphosphorylated during mitosis (Bailly
et al., 1991) . However, this study also showed that these pro-
teins were substrates in vitro of p34,*dc' and that their phos-
phorylation could not be detected in interphase extracts.
This result appears to conflict with the results of the present
study which suggest that p34cdcz is not responsible for the
inhibition of transport. At present the evidence that p34cncz
is responsible for the phosphorylation of rab lp observed in
mitotic cells remains indirect, and the possibility that it is
a substrate for protein kinases other than MPF cannot be ex-
cluded. However, it is also possible that modification of rab
lp is not directly related to the inhibition of transport. The
functional significance of the phosphorylation of rab lp re-
mains to be established .
Our results strongly suggest that MPF is not directly
responsible for the inhibition of vesicular transport that we
observe. However, we believe it likely that transport inhibi-
tion and the activation of MPF are related events. For exam-
ple, a single kinase might be involved in the regulation of
both processes, transport inhibition in mitosis could result
from a shift in the balance of phosphorylation/dephosphory-
lation as a consequence of MPF activation and be mimicked
by OKA and MC, or a protein kinase which is ordinarily a
substrate ofMPF might become prematurely activated in the
presence of OKA and MC. Alternatively, inhibition of PPs
might lead to the activation ofa kinase which phosphorylates
protein(s) involved in vesicular transport which are also sub-
strates of MPF during mitosis. Determination of which, if
any, of these hypotheses is correct and the establishment of
the relationship between the effects observed in vivo and in
vitro must await the identification of the relevant enzyme(s)
and substrate(s), problems which we are currently ad-
dressing.
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Note Added in Proof. After submission ofthis work we became aware of
a study reporting the OKA-mediated inhibition of intracellular transport in
intact HeLa cells (J. Lucocq, G. Warren, and J. Pryde. 1991 . J. Cell Sci.
100:753-759).
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